A previously elusive “molecular capsule” and various other structural motifs incorporating p -sulfonatocalix[4]arene are accessible by controlling the pH and by varying the stoichiometry of the calixarene relative to potential guest molecules and trivalent metal ions. The “molecular capsule” has monoprotonated 1-aza-18-crown-6 shrouded by two calixarenes, which hydrogen bond to aquated lanthanide ions. In contrast, the presence of 1-aza-15-crown-5 forms a complex devoid of the crown ether, with lanthanide ions directly bound to sulfonate groups. Also reported are a coordination polymer incorporating monoprotonated 1,4-diazabicyclo[2.2.2]octane in the cavity of one calixarene which forms chelate rings to lanthanide ions and the structure of a capsule with 4,13-diaza-18-crown-6 surrounded by two calixarenes which hydrogen bond to homoleptic aquated trivalent gallium ions.
No takes yet. Share an insight, caveat, or question.
Dalgarno et al. (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: